International evidence-based guideline for the assessment and management of polycystic ovary syndrome – 2023

Abstract

The evidence in the assessment and management of polycystic ovary syndrome (PCOS) has generally improved in the past five years, but remains of low to moderate quality. The technical evidence report and analyses underpins 77 evidence-based and 54 consensus recommendations, with 123 practice points.
Key updates include:
1)         further refinement of individual diagnostic criteria, a simplified diagnostic algorithm and inclusion of anti-Müllerian hormone levels as an alternative to ultrasound in adults only;
2)         strengthening recognition of broader features of PCOS including metabolic risk factors, cardiovascular disease, sleep apnea, very high prevalence of psychological features, and high risk status for adverse outcomes during pregnancy;
3)         emphasizing the poorly recognized, diverse burden of disease and the need for greater healthcare professional education, evidence-based patient information, improved models of care and shared decision making, alongside greater research;
4)         maintained emphasis on healthy lifestyle, emotional wellbeing and quality of life, with awareness and consideration of weight stigma;
5)         emphasizing evidence-based medical therapy and cheaper and safer fertility management.